omeprazole has been researched along with Intestinal Diseases in 11 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Li, K | 1 |
| Cheng, X | 1 |
| Jin, R | 1 |
| Han, T | 1 |
| Li, J | 1 |
| Satoh, H | 1 |
| Amagase, K | 1 |
| Takeuchi, K | 1 |
| Fujimori, S | 3 |
| Takahashi, Y | 2 |
| Tatsuguchi, A | 3 |
| Sakamoto, C | 3 |
| Seo, T | 2 |
| Gudis, K | 2 |
| Ehara, A | 2 |
| Kobayashi, T | 2 |
| Mitsui, K | 2 |
| Yonezawa, M | 2 |
| Tanaka, S | 2 |
| Yamada, Y | 1 |
| Endo, H | 1 |
| Higurashi, T | 1 |
| Hosono, K | 1 |
| Sakai, E | 1 |
| Sekino, Y | 1 |
| Iida, H | 1 |
| Sakamoto, Y | 1 |
| Koide, T | 1 |
| Takahashi, H | 1 |
| Yoneda, M | 1 |
| Tokoro, C | 1 |
| Inamori, M | 1 |
| Abe, Y | 1 |
| Nakajima, A | 1 |
| Mizukami, K | 1 |
| Murakami, K | 1 |
| Abe, T | 1 |
| Inoue, K | 1 |
| Uchida, M | 1 |
| Okimoto, T | 1 |
| Kodama, M | 1 |
| Fujioka, T | 1 |
| Maiden, L | 1 |
| Thjodleifsson, B | 1 |
| Theodors, A | 1 |
| Gonzalez, J | 1 |
| Bjarnason, I | 1 |
| Scheiman, JM | 1 |
| Goldstein, JL | 1 |
| Eisen, GM | 1 |
| Lewis, B | 1 |
| Gralnek, IM | 1 |
| Aisenberg, J | 1 |
| Bhadra, P | 1 |
| Berger, MF | 1 |
| Mazumder, DN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives[NCT03291743] | 38 participants (Actual) | Interventional | 2017-02-10 | Terminated (stopped due to Death of Principal Investigator) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for omeprazole and Intestinal Diseases
| Article | Year |
|---|---|
Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Diclofenac; Humans; Intestinal Di | 2009 |
Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Aspirin; Capsule Endoscopy; Dru | 2011 |
Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
Topics: Adult; Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsule E | 2011 |
A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Delayed-Action Preparations; Dicl | 2005 |
What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel?
Topics: Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Follow- | 2005 |
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Drug | 2007 |
5 other studies available for omeprazole and Intestinal Diseases
| Article | Year |
|---|---|
The influence of different proton pump inhibitors and potassium-competitive acid blockers on indomethacin-induced small intestinal injury.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; DNA, Ribo | 2022 |
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Respo | 2014 |
Omeprazole increased small intestinal mucosal injury in two of six disease-free cases evaluated by capsule endoscopy.
Topics: Adult; Capsule Endoscopy; Healthy Volunteers; Humans; Intestinal Diseases; Intestinal Mucosa; Intest | 2014 |
Distribution of small intestinal mucosal injuries as a result of NSAID administration.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Diclofenac; Humans; Intestinal Di | 2010 |
Omeprazole and enteric infection.
Topics: Duodenal Ulcer; Gram-Negative Bacterial Infections; Humans; Intestinal Diseases; Omeprazole | 1994 |